Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Denis Campbell Health policy editor

Shortage of ‘breakthrough’ weight loss drugs will slow fight against obesity, WHO warns

‘GLP-1 therapies mark more than a scientific breakthrough. They represent a new chapter in the gradual conceptual shift in how society approaches obesity.’
‘GLP-1 therapies mark more than a scientific breakthrough. They represent a new chapter in the gradual conceptual shift in how society approaches obesity.’ Photograph: Jon Challicom/Getty Images

Weight loss drugs such as Mounjaro offer huge potential to tackle soaring obesity globally but are currently only available to one in 10 of those who need them, the World Health Organization has said.

Their proven effectiveness in helping people lose weight means the medications represent “a new chapter” in how health services can treat obesity and the killer diseases it causes, the WHO added.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.